Biogen

BIIB • NASDAQ •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $2,200,300 $2,386,300 $2,530,300 $2,456,000
Gross Profit 1,510,500 1,768,000 1,870,700 1,863,300
EBITDA 693,000 623,200 371,700 708,600
EBIT 545,400 483,100 310,800 655,700
Net Income 393,400 249,700 -68,100 591,600
Net Change In Cash 2,200,300 2,386,300 2,530,300 2,456,000
Cost of Revenue -276,300
Free Cash Flow 432,300 -52,700 504,800 400,000
Cash 1,074,400 1,049,900 2,287,900 2,617,800
Basic Shares 145,900 145,700 144,800 145,500

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $9,835,600 $10,173,400 $10,981,700 $13,444,600
Gross Profit 7,302,200 7,895,100 8,872,000 11,639,400
EBITDA 2,598,900 2,686,100 3,656,600 4,807,300
EBIT 2,104,100 2,320,200 2,840,700 4,550,100
Net Income 1,161,100 3,046,900 1,556,100 4,000,600
Net Change In Cash 9,835,600 10,173,400 10,981,700 13,444,600
Cost of Revenue 1,213,600 990,000 -1,651,500
Free Cash Flow 1,235,800 1,141,100 3,345,000 3,678,000
Cash 1,049,900 3,419,300 2,261,400 1,331,200
Basic Shares 145,600 146,000 149,600 161,300

Earnings Calls

Quarter EPS
2024-03-31 $3.67
2023-12-31 $3.30
2023-09-30 $4.36
2023-06-30 $4.02